Download Files:
Cefuroxime
$389 – $623
Products Details
Product Description
– Cefuroxime is an orally active second-generation cephalosporin antibiotic with increased stability to β-lactamase. Cefuroxime has a broad spectrum activity against Gram-positive and Gram-negative bacteria[1].
Web ID
– HY-B1256A
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C16H16N4O8S
Citations
– Nat Commun. 2022 Mar 2;13(1):1116.|Nat Commun. 2023 Mar 22;14(1):1594.|Biomed Res Int. 2018 Jul 2;2018:3579832. |J Chem Inf Model. 2021 Mar 18.
References
– [1]Callaghan, et al. Cefuroxime, a New Cephalosporin Antibiotic: Activity in Vitro. Antimicrob Agents Chemother. 1976 Mar;9(3):511-9.|[2]D M Ryan, et al. Cefuroxime, a New Cephalosporin Antibiotic: Activity in Vivo. Antimicrob Agents Chemother. 1976 Mar;9(3):520-5.
CAS Number
– 55268-75-2
Molecular Weight
– 424.39
SMILES
– O=C(C(N12)=C(COC(N)=O)CS[C@]2([H])[C@H](NC(/C(C3=CC=CO3)=NOC)=O)C1=O)O
Clinical Information
– Launched
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– Antibiotic;Bacterial
Isoform
– β-lactam
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
